And we believe that repeated cycles of radiotherapy in combination with GM-CSF might have multiple immune-stimulatory effects and reduce tumor burden, which possibly maximize a continuously synergistic effect with PD-1 inhibitors. The gene discussed is CSF2; the disease is neoplasm.